Last update 11 Jul 2026

FKC-288

Overview

Basic Info

Drug Type
CAR-T
Synonyms
FKC 288, FKC288
Target
BCMA x CD19
Action
agonists, inhibitors
Mechanism
BCMA agonists(B-cell maturation protein agonists), CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), Immunologic cytotoxicity
Therapeutic Areas
NeoplasmsImmune System DiseasesEndocrinology and Metabolic Disease+ [2]
Active Indication-
Inactive Indication
Immunoglobulin Light-Chain Amyloidosis
Originator Organization
Nanjing UniversityNanjing University
Active Organization-
Inactive Organization
Nanjing UniversityNanjing University
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with FKC-288
NCT05978661
/ Unknown statusPhase 1IIT
A Single-Center Exploratory Study to Evaluate the Safety and Efficacy of FKC288 in Subjects With Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
100 Clinical Results associated with FKC-288
Login to view more data
100 Translational Medicine associated with FKC-288
Login to view more data
100 Patents (Medical) associated with FKC-288
Login to view more data
100 Deals associated with FKC-288
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Immunoglobulin Light-Chain AmyloidosisPhase 1
China
Nanjing UniversityNanjing University
29 Aug 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free